ABUS

#2156
Arbutus Biopharma Corporation Common Stock
4.66
-0.64%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
4.66
4.66
Jahresspanne
2.71
5.10
Tagesänderung
-0.64%
Monatliche Änderung
+11.75%
6 month change
+27.32%
Jahresänderung
+38.69%
Vorheriger Schlusskurs
4.69
Open
4.66
Bid
Ask
Low
4.66
High
4.66
Volumen
230
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics

Arbutus Biopharma Corporation

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.

Nachrichten